EPZM Annual EBIT
-$226.94 M
-$1.42 M-0.63%
31 December 2021
Summary:
As of February 5, 2025, EPZM annual earnings before interest & taxes is -$226.94 million, with the most recent change of -$1.42 million (-0.63%) on December 31, 2021. During the last 3 years, it has fallen by -$103.36 million (-83.65%).EPZM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EPZM Quarterly EBIT
-$29.76 M
+$19.74 M+39.88%
30 June 2022
Summary:
As of February 5, 2025, EPZM quarterly earnings before interest & taxes is -$29.76 million, with the most recent change of +$19.74 million (+39.88%) on June 30, 2022. Over the past year, it has increased by +$28.50 million (+48.92%).EPZM Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EPZM TTM EBIT
-$183.59 M
+$28.50 M+13.44%
30 June 2022
Summary:
As of February 5, 2025, EPZM TTM earnings before interest & taxes is -$183.59 million, with the most recent change of +$28.50 million (+13.44%) on June 30, 2022. Over the past year, it has increased by +$55.51 million (+23.22%).EPZM TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EPZM EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -0.6% | +48.9% | +23.2% |
| 3 y3 years | -83.7% | +38.6% | -8.0% |
| 5 y5 years | -68.5% | -4.6% | -8.0% |
EPZM EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | <-9999.0% | -283.1% | -4973.7% |
Epizyme EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | -$29.76 M(-39.9%) | -$183.59 M(-13.4%) |
| Mar 2022 | - | -$49.50 M(+11.0%) | -$212.10 M(-6.5%) |
| Dec 2021 | -$226.94 M(+0.6%) | -$44.58 M(-25.4%) | -$226.90 M(-7.2%) |
| Sept 2021 | - | -$59.74 M(+2.5%) | -$244.45 M(+2.2%) |
| June 2021 | - | -$58.27 M(-9.4%) | -$239.11 M(+0.3%) |
| Mar 2021 | - | -$64.30 M(+3.5%) | -$238.42 M(+6.1%) |
| Dec 2020 | -$225.51 M(+32.6%) | -$62.14 M(+14.2%) | -$224.76 M(+2.7%) |
| Sept 2020 | - | -$54.40 M(-5.5%) | -$218.77 M(+9.1%) |
| June 2020 | - | -$57.58 M(+13.7%) | -$200.46 M(+4.8%) |
| Mar 2020 | - | -$50.64 M(-9.8%) | -$191.35 M(+12.5%) |
| Dec 2019 | -$170.04 M(+37.6%) | -$56.15 M(+55.6%) | -$170.04 M(+27.2%) |
| Sept 2019 | - | -$36.09 M(-25.5%) | -$133.67 M(-1.8%) |
| June 2019 | - | -$48.46 M(+65.2%) | -$136.13 M(+15.4%) |
| Mar 2019 | - | -$29.34 M(+48.3%) | -$117.93 M(-4.6%) |
| Dec 2018 | -$123.57 M(-8.2%) | -$19.78 M(-48.7%) | -$123.58 M(-11.1%) |
| Sept 2018 | - | -$38.55 M(+27.4%) | -$138.96 M(+0.4%) |
| June 2018 | - | -$30.26 M(-13.5%) | -$138.46 M(+1.3%) |
| Mar 2018 | - | -$34.98 M(-0.5%) | -$136.66 M(+1.5%) |
| Dec 2017 | -$134.65 M | -$35.17 M(-7.6%) | -$134.65 M(-0.2%) |
| Sept 2017 | - | -$38.05 M(+33.7%) | -$134.96 M(+10.9%) |
| June 2017 | - | -$28.46 M(-13.7%) | -$121.74 M(+0.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | -$32.96 M(-7.1%) | -$121.68 M(+8.8%) |
| Dec 2016 | -$111.83 M(-15.6%) | -$35.48 M(+42.9%) | -$111.83 M(+13.4%) |
| Sept 2016 | - | -$24.83 M(-12.6%) | -$98.62 M(+1.8%) |
| June 2016 | - | -$28.40 M(+22.9%) | -$96.90 M(+2.8%) |
| Mar 2016 | - | -$23.11 M(+3.7%) | -$94.29 M(-28.9%) |
| Dec 2015 | -$132.55 M(+140.8%) | -$22.28 M(-3.6%) | -$132.55 M(+5.7%) |
| Sept 2015 | - | -$23.11 M(-10.4%) | -$125.36 M(+2.8%) |
| June 2015 | - | -$25.79 M(-58.0%) | -$121.99 M(+11.4%) |
| Mar 2015 | - | -$61.38 M(+306.7%) | -$109.52 M(+98.9%) |
| Dec 2014 | -$55.05 M(+1660.5%) | -$15.09 M(-23.5%) | -$55.05 M(+132.2%) |
| Sept 2014 | - | -$19.74 M(+48.3%) | -$23.70 M(+73.1%) |
| June 2014 | - | -$13.31 M(+92.6%) | -$13.70 M(+434.6%) |
| Mar 2014 | - | -$6.91 M(-142.5%) | -$2.56 M(-18.1%) |
| Dec 2013 | -$3.13 M(+307.2%) | $16.25 M(-267.1%) | -$3.13 M(-86.9%) |
| Sept 2013 | - | -$9.73 M(+346.8%) | -$23.92 M(+145.4%) |
| June 2013 | - | -$2.18 M(-70.9%) | -$9.75 M(+252.6%) |
| Mar 2013 | - | -$7.48 M(+64.9%) | -$2.76 M(+259.9%) |
| Dec 2012 | -$768.00 K(-96.3%) | -$4.54 M(-202.1%) | -$768.00 K(-120.4%) |
| Sept 2012 | - | $4.44 M(-7.5%) | $3.77 M(-657.2%) |
| June 2012 | - | $4.80 M(-187.7%) | -$676.00 K(-87.7%) |
| Mar 2012 | - | -$5.48 M | -$5.48 M |
| Dec 2011 | -$20.97 M | - | - |
FAQ
- What is Epizyme annual earnings before interest & taxes?
- What is the all time high annual EBIT for Epizyme?
- What is Epizyme annual EBIT year-on-year change?
- What is Epizyme quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Epizyme?
- What is Epizyme quarterly EBIT year-on-year change?
- What is Epizyme TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Epizyme?
- What is Epizyme TTM EBIT year-on-year change?
What is Epizyme annual earnings before interest & taxes?
The current annual EBIT of EPZM is -$226.94 M
What is the all time high annual EBIT for Epizyme?
Epizyme all-time high annual earnings before interest & taxes is $79.00 K
What is Epizyme annual EBIT year-on-year change?
Over the past year, EPZM annual earnings before interest & taxes has changed by -$1.42 M (-0.63%)
What is Epizyme quarterly earnings before interest & taxes?
The current quarterly EBIT of EPZM is -$29.76 M
What is the all time high quarterly EBIT for Epizyme?
Epizyme all-time high quarterly earnings before interest & taxes is $16.25 M
What is Epizyme quarterly EBIT year-on-year change?
Over the past year, EPZM quarterly earnings before interest & taxes has changed by +$28.50 M (+48.92%)
What is Epizyme TTM earnings before interest & taxes?
The current TTM EBIT of EPZM is -$183.59 M
What is the all time high TTM EBIT for Epizyme?
Epizyme all-time high TTM earnings before interest & taxes is $3.77 M
What is Epizyme TTM EBIT year-on-year change?
Over the past year, EPZM TTM earnings before interest & taxes has changed by +$55.51 M (+23.22%)